2,868
Participants
Start Date
February 16, 2018
Primary Completion Date
December 31, 2027
Study Completion Date
July 1, 2028
Aspirin 325mg
Aspirin 325 mg by mouth once daily
Enoxaparin 40Mg/0.4mL Prefilled Syringe
Enoxaparin 40 mg subcutaneous injection once daily
Johns Hopkins University, Baltimore
Moffitt Cancer Center, Tampa
Cleveland Clinic, Cleveland
University of Missouri-Columbia Cancer Care, Columbia
Louisiana State University Health, New Orleans
University of California Los Angeles Health, Los Angeles
Santiago Lozano-Calderon, Boston
Brigham and Women's Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Cooper University Health Care, Camden
Johns Hopkins University
OTHER
University of Missouri-Columbia
OTHER
Massachusetts General Hospital
OTHER